Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Professional License Rules topic

No spam. Unsubscribe anytime.

Senate panel approves streamlined licensure rules across multiple health professions; pharmacy compounding labeling language removed after stakeholder concerns

2610991 · January 21, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Senate Health and Welfare Committee approved a package of Idaho professional-license rule updates for pharmacists, physicians, physician assistants and several allied health professions. Committee members removed two subparts of a pharmacy compounding labeling rule after stakeholder concerns about federal guidance and access.

The Senate Health and Welfare Committee on the morning of the meeting reviewed and approved a series of rule dockets that rewrite and consolidate professional-licensure rules across several health boards, while taking specific changes for the Idaho State Board of Pharmacy after stakeholder concerns about compounded drug labeling.

Idaho State Board of Pharmacy: temporary rule expires; pending rule approved with labeling subparts struck Nikki Chopsky, bureau chief for health professions at the Division of Occupational and Professional Licenses and executive officer for the Idaho State Board of Pharmacy, told the committee the board conducted a comprehensive zero-based review that produced more than 35 changes to the pharmacy rules. The package reorganized definitions, moved duplicative language into statute, changed inventory cycles, updated reporting deadlines and moved fee tables into a single rule, among other changes. The board recommended the committee take no action on the earlier temporary docket (24-3601-2401) so it may expire; the committee voted to take no action on that temporary docket.

Compounding and labeling drew the most debate. Chopsky described stakeholder outreach and said the board retained a labeling provision that mirrors federal requirements for distribution of compounded products; she explained there are “legal pathways in Idaho for compounded products to be labeled and used,” and that some stakeholders raised concerns after recent federal draft guidance.

Senator Lenny moved to approve the pending pharmacy docket (24-3601-2402) while striking new rule 214, subsections (e)(i) and (e)(ii) — the provisions governing distribution/labeling of compounded drug products — arguing Idaho should seek an Idaho-specific solution and worried that strict state labeling could limit access if federal guidance evolves. After a roll-call, the substitute passed: the motion to approve the pending pharmacy docket with the strike of those subsections carried (vote recorded in the transcript as 7 yeas, 2 nays). Committee minutes show the committee approved the pending pharmacy rewrite with those subsections removed.

Board of Medicine and PA rules Division staff also presented a ZBR (zero-based review) consolidation of two Board of Medicine chapters (dockets 24-3301-2401 and 24-3303-2401) into a single chapter; the committee approved the replacement chapter and repeal of the prior chapter on a voice vote. The rewrite clarified definitions, relocated discipline and fee tables, and adjusted continuing medical education requirements to exempt physicians with board certification.

A separate physician-assistant (PA) rule docket (24-3302-2401) prompted contention over whether the rule should explicitly name the National Commission on Certification of Physician Assistants (NCCPA) and its exam. Senator Lenny moved to approve the PA docket while striking the clause that listed the NCCPA/exam. Senator Wintrow offered a substitute to approve the docket without the strike. The substitute failed on a roll-call (6 nays, 3 ayes) and the original motion to approve the PA docket with the strike of the rule listing NCCPA passed on voice vote. Division staff told the committee the NCCPA exam has been the longstanding examination used by PAs; removing the explicit organization will leave practice unchanged but would leave the statute/rule cross-reference gap unfilled until revisited.

Allied health dockets Staff also presented allied-health consolidations created after last session’s merger of several boards into an Allied Health Advisory Board. The committee approved pending rule packages for athletic trainers (24-3305-2401), respiratory therapists and polysomnographers (24-3306-2401), dietitians (24-3307-2401), and naturopathic medical doctors (24-3304-2401). Changes were largely organizational and removed duplicative or inconsistent inactive-license fees per Idaho Code 67-26-14(9); continuing education language for respiratory therapists was broadened to accept any CE considered germane to the profession.

Why it matters: The approved rule packages reorganize and streamline licensing and practice rules for multiple health professions, remove duplicative or statute-contradictory fees, and alter practice- or access-related language in pharmacy compounding labeling. The pharmacy labeling change reflects active stakeholder concern and legal uncertainty because the U.S. Food and Drug Administration has issued draft guidances that are not final; the board and committee chose to remove specific labeling subsections to avoid conflict while maintaining other federal-labeling cross-references.

Key quotes “Nikki Chopsky: ‘There are legal pathways in Idaho for compounded products to be labeled and used, and these products can also be administered by the prescriber or pharmacy staff.’”

“Senator Lenny: ‘I think Idaho should find an Idaho solution…If we take this out…the default is still kind of pointing to federal regulation.’”

What the committee decided (summary of formal actions) - Temporary pharmacy docket 24-3601-2401 — motion to take no action: passed (voice vote). - Pending pharmacy docket 24-3601-2402 — motion to approve pending docket while striking rule 214(e)(i) and 214(e)(ii): passed on roll-call (7 yes, 2 no). - Board of Medicine rewrite dockets 24-3301-2401 and repeal of 24-3303-2401 — approve pending chapter and repeal prior chapter: passed (voice vote). - PA docket 24-3302-2401 — motion to approve pending docket while striking the clause listing NCCPA/exam: original motion carried after substitute failed on roll-call; outcome: PA docket approved with the NCCPA clause removed. - Athletic trainers (24-3305-2401), respiratory therapists and polysomnographers (24-3306-2401), dietitians (24-3307-2401), and naturopathic medical doctors (24-3304-2401) — approved (voice votes); inactive-license renewal fee lines struck to conform with Idaho Code 67-26-14(9).

What remains: The Board of Pharmacy indicated it will continue stakeholder engagement on compounding distribution and labeling and may revisit rule language through standard rulemaking if federal guidance changes or stakeholder proposals emerge. The committee will resume administrative rule dockets at its next meeting.